Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Schaaf

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Leukocyte Biology|June 7, 2011
Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expressionPeter Uciechowski, Heidi Imhoff, Christoph Lange, et al.
European Journal of Immunology|March 5, 2022
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationDoris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Performance of T-Track<sup>®</sup> TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active TuberculosisJohannes P Meier, Selina Möbus, Florian Heigl, et al.
Critical Care (London, England)|March 6, 2020
Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trialChristopher Adlbrecht, Raphael Wurm, Pieter Depuydt, et al.
Pneumologie (Stuttgart, Germany)|November 21, 2025
[Summary of the update to the S3 guideline: Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of ImmunotherapyAnna Kron, Matthias Scheffler, Carina Heydt, et al.
Nature Communications|November 9, 2018
Overcoming EGFR<sup>G724S</sup>-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitorsJana Fassunke, Fabienne Müller, Marina Keul, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Leukocyte Biology|June 7, 2011
Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expressionPeter Uciechowski, Heidi Imhoff, Christoph Lange, et al.
European Journal of Immunology|March 5, 2022
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationDoris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Performance of T-Track<sup>®</sup> TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active TuberculosisJohannes P Meier, Selina Möbus, Florian Heigl, et al.
Critical Care (London, England)|March 6, 2020
Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trialChristopher Adlbrecht, Raphael Wurm, Pieter Depuydt, et al.
Pneumologie (Stuttgart, Germany)|November 21, 2025
[Summary of the update to the S3 guideline: Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of ImmunotherapyAnna Kron, Matthias Scheffler, Carina Heydt, et al.
Nature Communications|November 9, 2018
Overcoming EGFR<sup>G724S</sup>-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitorsJana Fassunke, Fabienne Müller, Marina Keul, et al.
Pageof 3